{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T03:44:08Z","timestamp":1767843848697,"version":"3.49.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T00:00:00Z","timestamp":1538956800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T00:00:00Z","timestamp":1538956800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K01DA040023"],"award-info":[{"award-number":["K01DA040023"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K23DA038726"],"award-info":[{"award-number":["K23DA038726"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA029840"],"award-info":[{"award-number":["R01DA029840"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI Phys"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s40658-018-0219-6","type":"journal-article","created":{"date-parts":[[2018,6,18]],"date-time":"2018-06-18T11:41:00Z","timestamp":1529322060000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Validation of gallbladder absorbed radiation dose reduction simulation: human dosimetry of [18F]fluortriopride"],"prefix":"10.1186","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1747-239X","authenticated-orcid":false,"given":"Robert K.","family":"Doot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob G.","family":"Dubroff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua S.","family":"Scheuermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyle J.","family":"Labban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenny","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Ju","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shihong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsiaoju","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin K.","family":"Schubert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Regan","family":"Sheffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuiying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert H.","family":"Mach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,10,8]]},"reference":[{"issue":"1","key":"219_CR1","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1152\/physrev.1998.78.1.189","volume":"78","author":"C Missale","year":"1998","unstructured":"Missale C, Nash SR, Robinson SW, Jaber M, Caron MG. Dopamine receptors: from structure to function. Physiol Rev. 1998;78(1):189\u2013225.","journal-title":"Physiol Rev"},{"issue":"8","key":"219_CR2","doi-asserted-by":"publisher","first-page":"643","DOI":"10.2174\/1381612033391199","volume":"9","author":"RR Luedtke","year":"2003","unstructured":"Luedtke RR, Mach RH. Progress in developing D3 dopamine receptor ligands as potential therapeutic agents for neurological and neuropsychiatric disorders. Curr Pharm Design. 2003;9(8):643\u201371.","journal-title":"Curr Pharm Design"},{"key":"219_CR3","unstructured":"Mach RH, Luedtke RR. Challenges in the development of dopamine D2- and D3-selective radiotracers for PET imaging studies. J Labelled Comp Radiopharm. 2017;61(3):291\u20138."},{"issue":"19","key":"219_CR4","doi-asserted-by":"publisher","first-page":"8942","DOI":"10.1073\/pnas.90.19.8942","volume":"90","author":"C Schmauss","year":"1993","unstructured":"Schmauss C, Haroutunian V, Davis KL, Davidson M. Selective loss of dopamine D3-type receptor mRNA expression in parietal and motor cortices of patients with chronic schizophrenia. Proc Natl Acad Sci U S A. 1993;90(19):8942\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"219_CR5","doi-asserted-by":"publisher","first-page":"3663","DOI":"10.1021\/jm040190e","volume":"48","author":"AH Newman","year":"2005","unstructured":"Newman AH, Grundt P, Nader MA. Dopamine D3 receptor partial agonists and antagonists as potential drug abuse therapeutic agents. J Med Chem. 2005;48(11):3663\u201379.","journal-title":"J Med Chem"},{"issue":"7","key":"219_CR6","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.bcp.2012.06.023","volume":"84","author":"AH Newman","year":"2012","unstructured":"Newman AH, Blaylock BL, Nader MA, Bergman J, Sibley DR, Skolnick P. Medication discovery for addiction: translating the dopamine D3 receptor hypothesis. Biochem Pharmacol. 2012;84(7):882\u201390.","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"219_CR7","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/npp.2012.171","volume":"38","author":"M Mugnaini","year":"2013","unstructured":"Mugnaini M, Iavarone L, Cavallini P, Griffante C, Oliosi B, Savoia C, et al. Occupancy of brain dopamine D3 receptors and drug craving: a translational approach. Neuropsychopharmacology. 2013;38(2):302\u201312.","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"219_CR8","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1017\/S1461145712000661","volume":"16","author":"J Bergman","year":"2013","unstructured":"Bergman J, Roof RA, Furman CA, Conroy JL, Mello NK, Sibley DR, et al. Modification of cocaine self-administration by buspirone (buspar(R)): potential involvement of D3 and D4 dopamine receptors. Int J Neuropsychopharmacol. 2013;16(2):445\u201358.","journal-title":"Int J Neuropsychopharmacol"},{"key":"219_CR9","unstructured":"Payer D, Balasubramaniam G, Boileau I. What is the role of the D receptor in addiction? A mini review of PET studies with [C]-(+)-PHNO. Prog Neuro-Psychopharmacol Biol Psychiatry. 2013;61(3):291\u20138."},{"key":"219_CR10","first-page":"135","volume":"7","author":"ME McIlwain","year":"2011","unstructured":"McIlwain ME, Harrison J, Wheeler AJ, Russell BR. Pharmacotherapy for treatment-resistant schizophrenia. Neuropsychiatr Dis Treat. 2011;7:135\u201349.","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"4","key":"219_CR11","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s002130050356","volume":"132","author":"J Hietala","year":"1997","unstructured":"Hietala J, Kuoppamaki M, Nagren K, Lehikoinen P, Syvalahti E. Effects of lorazepam administration on striatal dopamine D2 receptor binding characteristics in man\u2014a positron emission tomography study. Psychopharmacology. 1997;132(4):361\u20135.","journal-title":"Psychopharmacology"},{"issue":"3","key":"219_CR12","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1002\/syn.10128","volume":"46","author":"J Mukherjee","year":"2002","unstructured":"Mukherjee J, Christian BT, Dunigan KA, Shi B, Narayanan TK, Satter M, et al. Brain imaging of 18F-fallypride in normal volunteers: blood analysis, distribution, test-retest studies, and preliminary assessment of sensitivity to aging effects on dopamine D-2\/D-3 receptors. Synapse. 2002;46(3):170\u201388.","journal-title":"Synapse"},{"issue":"4","key":"219_CR13","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1038\/npp.2013.286","volume":"39","author":"JD Gallezot","year":"2014","unstructured":"Gallezot JD, Kloczynski T, Weinzimmer D, Labaree D, Zheng MQ, Lim K, et al. Imaging nicotine- and amphetamine-induced dopamine release in rhesus monkeys with [(11)C]PHNO vs [(11)C]raclopride PET. Neuropsychopharmacology. 2014;39(4):866\u201374.","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"219_CR14","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.neuroimage.2010.06.044","volume":"54","author":"AC Tziortzi","year":"2011","unstructured":"Tziortzi AC, Searle GE, Tzimopoulou S, Salinas C, Beaver JD, Jenkinson M, et al. Imaging dopamine receptors in humans with [11C]-(+)-PHNO: dissection of D3 signal and anatomy. NeuroImage. 2011;54(1):264\u201377.","journal-title":"NeuroImage"},{"issue":"6","key":"219_CR15","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1021\/jm101323b","volume":"54","author":"Z Tu","year":"2011","unstructured":"Tu Z, Li S, Cui J, Xu J, Taylor M, Ho D, et al. Synthesis and pharmacological evaluation of fluorine-containing D(3) dopamine receptor ligands. J Med Chem. 2011;54(6):1555\u201364.","journal-title":"J Med Chem"},{"issue":"8","key":"219_CR16","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1002\/syn.20891","volume":"65","author":"RH Mach","year":"2011","unstructured":"Mach RH, Tu Z, Xu J, Li S, Jones LA, Taylor M, et al. Endogenous dopamine (DA) competes with the binding of a radiolabeled D(3) receptor partial agonist in vivo: a positron emission tomography study. Synapse. 2011;65(8):724\u201332.","journal-title":"Synapse"},{"issue":"6","key":"219_CR17","first-page":"301","volume":"6","author":"R Laforest","year":"2016","unstructured":"Laforest R, Karimi M, Moerlein SM, Xu J, Flores HP, Bognar C, et al. Absorbed radiation dosimetry of the D3-specific PET radioligand [18F]FluorTriopride estimated using rodent and nonhuman primate. Am J Nucl Med Mol Imaging. 2016;6(6):301\u20139.","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"219_CR18","unstructured":"United States Federal Regulations for Radioactive Drugs for Certain Research Uses (21CFR361.1). Prescription drugs for human use generally recognized as safe and effective and not misbranded: drugs used in research, (2017)."},{"issue":"14","key":"219_CR19","doi-asserted-by":"publisher","first-page":"3843","DOI":"10.1088\/0031-9155\/59\/14\/3843","volume":"59","author":"JA Kolthammer","year":"2014","unstructured":"Kolthammer JA, Su KH, Grover A, Narayanan M, Jordan DW, Muzic RF. Performance evaluation of the ingenuity TF PET\/CT scanner with a focus on high count-rate conditions. Phys Med Biol. 2014;59(14):3843\u201359.","journal-title":"Phys Med Biol"},{"key":"219_CR20","doi-asserted-by":"crossref","unstructured":"White DR, Booz J, Griffith RV, Spokas JJ, Wilson IJ. Report 44. J Int Commission Radiation Units Meas 1989;os23(1):NP-NP.","DOI":"10.1093\/jicru\/os23.1.Report44"},{"key":"219_CR21","doi-asserted-by":"crossref","unstructured":"International Commission on Radiological Protection. Basic anatomical & physiological data for use in radiological protection\u2014the skeleton. ICRP publication 70, Table 47. Ann ICRP 1995;25(2):1\u201380.","DOI":"10.1016\/S0146-6453(00)80004-4"},{"issue":"6","key":"219_CR22","first-page":"1023","volume":"46","author":"MG Stabin","year":"2005","unstructured":"Stabin MG, Sparks RB, Crowe E. OLINDA\/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine. J Nucl Med. 2005;46(6):1023\u20137.","journal-title":"J Nucl Med"},{"issue":"8","key":"219_CR23","first-page":"1263","volume":"44","author":"HA Ziessman","year":"2003","unstructured":"Ziessman HA, Jones DA, Muenz LR, Agarval AK. Cholecystokinin cholescintigraphy: methodology and normal values using a lactose-free fatty-meal food supplement. J Nucl Med. 2003;44(8):1263\u20136.","journal-title":"J Nucl Med"},{"issue":"21\u201322","key":"219_CR24","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1016\/j.drudis.2012.07.002","volume":"17","author":"SJ Hosseinimehr","year":"2012","unstructured":"Hosseinimehr SJ, Tolmachev V, Orlova A. Liver uptake of radiolabeled targeting proteins and peptides: considerations for targeting peptide conjugate design. Drug Discov Today. 2012;17(21\u201322):1224\u201332.","journal-title":"Drug Discov Today"},{"issue":"20","key":"219_CR25","doi-asserted-by":"publisher","first-page":"3110","DOI":"10.1002\/jssc.200900879","volume":"33","author":"C Onisor","year":"2010","unstructured":"Onisor C, Posa M, Kevresan S, Kuhajda K, Sarbu C. Estimation of chromatographic lipophilicity of bile acids and their derivatives by reversed-phase thin layer chromatography. J Sep Sci. 2010;33(20):3110\u20138.","journal-title":"J Sep Sci"},{"issue":"1","key":"219_CR26","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/RLU.0b013e31823e26bb","volume":"37","author":"JK DiBaise","year":"2012","unstructured":"DiBaise JK, Richmond BK, Ziessman HA, Everson GT, Fanelli RD, Maurer AH, et al. Cholecystokinin-cholescintigraphy in adults: consensus recommendations of an interdisciplinary panel. Clin Nucl Med. 2012;37(1):63\u201370.","journal-title":"Clin Nucl Med"},{"issue":"1\u20133","key":"219_CR27","first-page":"1","volume":"21","author":"The 1990 Recommendations of the International Commission on Radiological Protection","year":"1991","unstructured":"The 1990 Recommendations of the International Commission on Radiological Protection. ICRP publication 60. Ann ICRP. 1991;21(1\u20133):1\u2013201.","journal-title":"Ann ICRP"},{"issue":"3","key":"219_CR28","doi-asserted-by":"publisher","first-page":"445","DOI":"10.2967\/jnumed.116.178483","volume":"58","author":"S Okamoto","year":"2017","unstructured":"Okamoto S, Thieme A, Allmann J, D'Alessandria C, Maurer T, Retz M, et al. Radiation dosimetry for 177Lu-PSMA I&T in metastatic castration-resistant prostate cancer: absorbed dose in normal organs and tumor lesions. J Nucl Med. 2017;58(3):445\u201350.","journal-title":"J Nucl Med"},{"issue":"9","key":"219_CR29","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1007\/s00259-017-3678-4","volume":"44","author":"A Sundlov","year":"2017","unstructured":"Sundlov A, Sjogreen-Gleisner K, Svensson J, Ljungberg M, Olsson T, Bernhardt P, et al. Individualised 177Lu-DOTATATE treatment of neuroendocrine tumours based on kidney dosimetry. Eur J Nucl Med Mol Imaging. 2017;44(9):1480\u20139.","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["EJNMMI Physics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40658-018-0219-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40658-018-0219-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40658-018-0219-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T23:44:55Z","timestamp":1589672695000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejnmmiphys.springeropen.com\/articles\/10.1186\/s40658-018-0219-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,8]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["219"],"URL":"https:\/\/doi.org\/10.1186\/s40658-018-0219-6","relation":{},"ISSN":["2197-7364"],"issn-type":[{"value":"2197-7364","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,8]]},"assertion":[{"value":"16 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures were approved by the University of Pennsylvania Institutional Review Board (FWA00004028), and the  Identifier is NCT02379338. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The informed consent obtained in writing from all individual participants prior to inclusion in the study includes consent for publication of de-identified summary data and individual sample images.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"21"}}